Improving lives with precision diagnostics® for informed treatment decisions in myelo- and lympho-proliferative disorders. #Oncology#MFC#NGS#ClinicalTrials
Attending #EHA2026? Stop by Booth D1.03 👋
Connect with our #Invivoscribe team to learn how our #clonality and ultra-sensitive #MRD solutions accelerate drug development and support the future of precision medicine worldwide.
The #Invivoscribe team walked away w/new connections, had meaningful conversations & gained a deeper appreciation for the #oncology community that we're proud to be part of. Thank you to everyone who stopped. We'll see you next year!
#PrecisionMedicine#AML#ClinicalTrials
#Invivoscribe is proud to share an abstract at #ASCO. The study evaluated #FlowER, a fully automated #AI algorithm designed to identify phenotypically aberrant cells from multiparametric #FlowCytometry data w/out relying on...Learn more here: hubs.ly/Q04jd9N40